At the end of 2012, Richard Holland, our Chief Business Officer, made a series of predictions about what would happen in 2013. With the end of the year fast approaching, we take this opportunity to look back and see how well our resident..
I'm no patent lawyer but when a colleague passed me a link to a patent application from Illumina which appears to lay claim to having invented the concept of analyzing biological data in the cloud, I couldn't help but wonder what on earth they think..
In the wake of Eagle’s successful fund-raising, I was kindly invited to speak on a panel for Scottish life-science entrepreneurs in Edinburgh as part of a two-day master-class organised by Eagle’s good friends at BioLauncher. As ever, it was lovely..
While the bioinformatics revolution is well under way in life sciences, it is slowly making progress into the consumer sector, with companies now adopting the same approach to improve a range of consumer products. Whether in the fast moving..
In our occasional series of guest blog articles, we are proud to present a piece on the topic of big data in biology, written by C. Titus Brown. This article has been reproduced from the original with his permission.
Eagle, as many readers will know, is based on the Babraham Research Campus, near Cambridge, UK. Babraham has worked really well for us, providing flexible space, plenty of resources and facilities to use that would be otherwise very hard to gain..
In September, Om Kulkarni joined Eagle for a six month placement as part of his Marie Curie Fellowship. I asked Om a few questions about his research interests, why he chose to work with Eagle, and what he is hoping to achieve over the next six..
In a recent post our CTO Will Spooner discussed the benefits of the 'blackboard' approach to NGS software pipelines and how this has been used by the developers of eHive at the European Bioinformatics Institute (EBI). The eHive tool is used there..